Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes

References

• Milech A Angelucci AP Golbert A Diretrizes Da Sociedade Brasileira de Diabetes 2015–2016 de Oliveira JEP Vencio S São Paulo AC Farmacêutica 2016 Available from: http://www.diabetes.org.br/profissionais/images/docs/DIRETRIZES-SBD-2015-2016.pdf
   Google Scholar
• Petersen KF Shulman GI Etiology of insulin resistance Am J Med 2006 119 5 Suppl 1 S10 S16 16563942
   PubMed Web of Science ®Google Scholar
• Atkinson MA Eisenbarth GS Michels AW Type 1 diabetes Lancet 2014 383 9911 69 82 23890997
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation IDF Diabetes Atlas 7th ed 2015 Available from: http:/www.diabetesatlas.org Accessed February 1, 2018
   Google Scholar
• World Health Organization Global Report on Diabetes 2016 Available in http://www.who.int/iris/handle/10665/204871 Accessed February 1, 2018
   Google Scholar
• American Diabetes Association (ADA) Standard of medical care in diabetes - 2017 Diabetes Care 2017 40 Suppl 1 s4 s5 27979887
   PubMedGoogle Scholar
• Purohit S She JX Biomarkers for type 1 diabetes Int J Clin Exp Med 2008 1 2 98 116 19079665
   PubMed Web of Science ®Google Scholar
• Sosenko JM Krischer JP Palmer JP A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1 Diabetes Care 2008 31 3 528 533 18000175
   PubMed Web of Science ®Google Scholar
• Chen CC Lu YC Chen YW Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: role of glucose-induced ROS J Proteomics 2012 75 12 3760 3777 22579751
   PubMed Web of Science ®Google Scholar
• Zhi W Sharma A Purohit S Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays Mol Cell Proteomics 2011 10 11 M111.012203
   Web of Science ®Google Scholar
• Sundsten T Ortsater H Proteomics in diabetes research Mol Cell Endocrinol 2009 297 1–2 93 103 18657591
   PubMed Web of Science ®Google Scholar
• Neilson KA Ali NA Muralidharan S Less label, more free: approaches in label-free quantitative mass spectrometry Proteomics 2011 11 4 535 553 21243637
   PubMed Web of Science ®Google Scholar
• Silva JC Gorenstein MV Li GZ Vissers JP Geromanos SJ Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition Mol Cell Proteomics 2006 5 1 144 156 16219938
   PubMed Web of Science ®Google Scholar
• SISVAN Orientações Básicas Para a Coleta, Processamento, Análise de Dados E Informação Em Serviços de Saúde 2004
   Google Scholar
• WHO Expert Committee on Physical Status: the use and interpretation of anthropmetry Physical status: the use of and interpretation of anthropometry: report of a WHO expert committee 1995 854 1 4520
   Google Scholar
• World Health Organization Global Status Report on Alcohol. Department of Mental Health and Substance Abuse 2004
   Google Scholar
• Schoenborn CA Adams PE Health behaviors of adults: United States, 2005–2007 Vital Health Stat 10 2010 245 1 132
   Google Scholar
• Friedewald WT Levy RI Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 1972 18 6 499 502 4337382
   PubMed Web of Science ®Google Scholar
• Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 1976 72 248 254 942051
   PubMed Web of Science ®Google Scholar
• Li GZ Vissers JP Silva JC Golick D Gorenstein MV Geromanos SJ Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures Proteomics 2009 9 6 1696 1719 19294629
   PubMed Web of Science ®Google Scholar
• Sparre T Larsen MR Heding PE Karlsen AE Jensen ON Pociot F Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions Mol Cell Proteomics 2005 4 4 441 457 15699484
   PubMed Web of Science ®Google Scholar
• Rehman AA Ahsan H Khan FH Alpha-2-macroglobulin: a physiological guardian J Cell Physiol 2013 228 8 1665 1675 23086799
   PubMed Web of Science ®Google Scholar
• Takada T Kodera Y Matsubara M Serum monomeric α2-macroglobulin as a clinical biomarker in diabetes Atherosclerosis 2013 228 1 270 276 23535567
   PubMed Web of Science ®Google Scholar
• Caseiro A Barros A Ferreira R Pursuing type 1 diabetes mellitus and related complications through urinary proteomics Transl Res 2014 163 3 188 199 24096133
   PubMed Web of Science ®Google Scholar
• Lu CH Lin ST Chou HC Lee YR Chan HL Proteomic analysis of retinopathy-related plasma biomarkers in diabetic patients Arch Biochem Biophys 2013 529 2 146 156 23220024
   PubMed Web of Science ®Google Scholar
• Athippozhy A Huang L Wooton-Kee CR Differential gene expression in liver and small intestine from lactating rats compared to age-matched virgin controls detects increased mRNA of cholesterol biosynthetic genes BMC Genomics 2011 12 95 21291544
   PubMed Web of Science ®Google Scholar
• Schroeder HW Cavacini L Structure and function of immunoglobulins J Allergy Clin Immunol 2010 125 2 Suppl 2 S41 S52 20176268
   PubMed Web of Science ®Google Scholar
• Woof JM Russell MW Structure and function relationships in IgA Mucosal Immunol 2011 4 6 590 597 21937984
   PubMed Web of Science ®Google Scholar
• Triolo G Giardina E Zarcone MR Giordano C Rinaldi A Bompiani GD Contribution of secretory IgA, polymeric IgA and IgA/secretory component-containing circulating immune complexes to the serum hyper-IgA in diabetes mellitus Diabetologia 1984 27 Suppl 157 159 6479489
   PubMed Web of Science ®Google Scholar
• Figueredo A Ibarra JL Rodriguez A Increased serum levels of IgA antibodies to hsp70 protein in patients with diabetes mellitus: their relationship with vascular complications Clin Immunol Immunopathol 1996 79 3 252 255 8635283
   PubMedGoogle Scholar
• Rodriguez-Segade S Camiña MF Carnero A High serum IgA concentrations in patients with diabetes mellitus: agewise distribution and relation to chronic complications Clin Chem 1996 42 7 1064 1067 8674189
   PubMed Web of Science ®Google Scholar
• Jaleel A Halvatsiotis P Williamson B Juhasz P Martin S Nair KS Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment Diabetes Care 2005 28 3 645 652 15735202
   PubMed Web of Science ®Google Scholar
• Singh AK Kingston JJ Gupta SK Batra HV Recombinant bivalent fusion protein rVE induces CD4+ and CD8+ T-cell mediated memory immune response for protection against yersinia enterocolitica infection Front Microbiol 2015 6 1407 26733956
   PubMed Web of Science ®Google Scholar
• Gonzalez-Quintela A Alende R Gude F Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities Clin Exp Immunol 2007 151 1 42 50 18005364
   PubMed Web of Science ®Google Scholar
• Castellani LW Goto AM Lusis AJ Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance Diabetes 2001 50 3 643 651 11246886
   PubMed Web of Science ®Google Scholar
• Castellani LW Nguyen CN Charugundla S Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance J Biol Chem 2008 283 17 11633 11644 18160395
   PubMed Web of Science ®Google Scholar
• Feitosa AC Feitosa-Filho GS Freitas FR Wajchenberg BL Maranhão RC Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment Lipids Health Dis 2013 12 15 23398881
   PubMed Web of Science ®Google Scholar
• Pérez A Caixàs A Carreras G Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control Diabetes Res Clin Pract 1997 36 2 83 90 9229192
   PubMed Web of Science ®Google Scholar
• Vergès B Lipid disorders in type 1 diabetes Diabetes Metab 2009 35 5 353 360 19733492
   PubMed Web of Science ®Google Scholar
• Overgaard AJ Hansen HG Lajer M Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy Proteome Sci 2010 8 4 20205888
   PubMed Web of Science ®Google Scholar
• Soedamah-Muthu SS Colhoun HM Taskinen MR Idzior-Walus B Fuller JH EURODIAB IDDM Complications Study Group Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients Diabetologia 2000 43 11 1353 1359 11126402
   PubMed Web of Science ®Google Scholar
• Hedrick CC Castellani LW Wong H Lusis AJ In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions J Lipid Res 2001 42 4 563 570 11290828
   PubMed Web of Science ®Google Scholar
• Boucher J Ramsamy TA Braschi S Sahoo D Neville TA Sparks DL Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity J Lipid Res 2004 45 5 849 858 14967812
   PubMed Web of Science ®Google Scholar
• Julve J Muñoz García C Santos D Blanco-Vaca F Escolà-Gil JC La apolipoproteína A-II altera la composición apolipoproteica de HDL y su capacidad para activar la lipoproteína lipasa Clin Investig Arterioscler 2010 22 5 192 197
   Google Scholar
• Pownall HJ Gillard BK Gotto AM Setting the course for apoAII: a port in sight? Clin Lipidol 2013 8 5 551 560 25067958
   PubMed Web of Science ®Google Scholar
• Castro A Lázaro I Selva DM APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome Atherosclerosis 2010 209 1 201 205 19878946
   PubMed Web of Science ®Google Scholar
• Gómez-Cardona EE Hernández-Domínguez EE Velarde-Salcedo AJ 2D-DIGE as a strategy to identify serum biomarkers in Mexican patients with type-2 diabetes with different body mass index Sci Rep 2017 7 46536 28425473
   PubMed Web of Science ®Google Scholar
• Ouchi Y Yoshikawa E Sekine Y Microglial activation and dopamine terminal loss in early Parkinson’s disease Ann Neurol 2005 57 2 168 175 15668962
   PubMed Web of Science ®Google Scholar
• Simó R Higuera M García-Ramírez M Canals F García-Arumí J Hernández C Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients Arch Ophthalmol 2008 126 8 1076 18695102
   PubMedGoogle Scholar
• Chonn A Semple SC Cullis PR Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of “non-self ” particles J Biol Chem 1995 270 43 25845 25849 7592769
   PubMed Web of Science ®Google Scholar
• Lee SC Pervaiz S Apoptosis in the pathophysiology of diabetes mellitus Int J Biochem Cell Biol 2007 39 3 497 504 17074529
   PubMed Web of Science ®Google Scholar
• Mizuno M Suzuki Y Ito Y Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology Clin Exp Nephrol 2018 22 1 3 14 28341889
   PubMed Web of Science ®Google Scholar
• Charlesworth JA Timmermans V Golding J The complement system in type 1 (insulin-dependent) diabetes Diabetologia 1987 30 6 372 379 3678658
   PubMed Web of Science ®Google Scholar
• Liberatore RR Barbosa SF Alkimin Md Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus Pediatr Diabetes 2005 6 4 206 212 16390389
   PubMed Web of Science ®Google Scholar
• Turina M Fry DE Polk HC Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects Crit Care Med 2005 33 7 1624 1633 16003073
   PubMed Web of Science ®Google Scholar
• Ekström B Peterson PA Berggárd I A urinary and plasma α1-glycoprotein of low molecular weight: Isolation and some properties Biochem Biophys Res Commun 1975 65 4 1427 1433 79416
   PubMed Web of Science ®Google Scholar
• Soggiu A Piras C Bonizzi L Hussein HA Pisanu S Roncada P A discovery-phase urine proteomics investigation in type 1 diabetes Acta Diabetol 2012 49 6 453 464 22678621
   PubMed Web of Science ®Google Scholar
• Gluhovschi C Gluhovschi G Petrica L Urinary biomarkers in the assessment of early diabetic nephropathy J Diabetes Res 2016 2016 1 13
   Web of Science ®Google Scholar
• Pfleiderer S Zimmerhackl LB Kinne R Manz F Schuler G Brandis M Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein Clin Investig 1993 71 12 972 977
   PubMedGoogle Scholar
• Varghese SA Powell TB Budisavljevic MN Urine biomarkers predict the cause of glomerular disease J Am Soc Nephrol 2007 18 3 913 922 17301191
   PubMed Web of Science ®Google Scholar
• Aregger F Uehlinger DE Witowski J Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury Kidney Int 2014 85 4 909 919 24067438
   PubMed Web of Science ®Google Scholar
• Korenkova V Jones A Hoy WE Morais C Cooper MA Gobe GC Urinary biomarkers for detection of early and advanced chronic kidney disease – a pilot study Med Chem (Los Angeles) 2015 5 2 96 103
   Google Scholar
• Alzahrani S Ajjan R Review article: coagulation and fibrinolysis in diabetes Diabetes Vasc Dis Res 2010 7 4 260 273
   PubMed Web of Science ®Google Scholar
• Ceriello A Esposito K Ihnat M Zhang J Giugliano D Simultaneous control of hyperglycemia and oxidative stress normalizes enhanced thrombin generation in type 1 diabetes J Thromb Haemost 2009 7 7 1228 1230 19422461
   PubMed Web of Science ®Google Scholar
• Sauls DL Banini AE Boyd LC Hoffman M Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes J Thromb Haemost 2007 5 3 638 639 17166250
   PubMed Web of Science ®Google Scholar
• Skornicka EL Kiyatkina N Weber MC Tykocinski ML Koo PH Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production Cell Immunol 2004 232 1–2 144 156 15882859
   PubMed Web of Science ®Google Scholar
• Devriendt K Van den Berghe H Cassiman JJ Marynen P Primary structure of pregnancy zone protein. Molecular cloning of a full-length PZP cDNA clone by the polymerase chain reaction Biochim Biophys Acta 1991 1088 1 95 103 1989698
   PubMed Web of Science ®Google Scholar
• Stimson WH Studies on the immunosuppressive properties of a pregnancy-associated alpha-macroglobulin Clin Exp Immunol 1976 25 2 199 206 60185
   PubMed Web of Science ®Google Scholar
• Folkersen J Teisner B Grunnet N Grudzinskas JG Westergaard JG Hindersson P Circulating levels of pregnancy zone protein: normal range and the influence of age and gender Clin Chim Acta 1981 110 2–3 139 145 7226526
   PubMed Web of Science ®Google Scholar
• Horne CHW Schoultz B Towler CM Damber MG Stigbrand T Gibb LM Serum pregnancy-associated α2-glycoprotein levels in autoimmune diseases Vox Sang 1978 34 6 329 334 664562
   PubMed Web of Science ®Google Scholar
• IJsselstijn L Dekker LJ Stingl C Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer’s disease J Proteome Res 2011 10 11 4902 4910 21879768
   PubMed Web of Science ®Google Scholar
• Wu SM Pizzo SV Mechanism of hypochlorite-mediated inactivation of proteinase inhibition by alpha 2-macroglobulin Biochemistry 1999 38 42 13983 13990 10529245
   PubMed Web of Science ®Google Scholar
• Bending D Zaccone P Cooke A Inflammation and type one diabetes Int Immunol 2012 24 6 339 346 22447815
   PubMed Web of Science ®Google Scholar
• Snell-Bergeon JK West NA Mayer-Davis EJ Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH case-control study J Clin Endocrinol Metab 2010 95 6 2868 2876 20371668
   PubMed Web of Science ®Google Scholar
• Xiang Y Zhou P Li X Heterogeneity of altered cytokine levels across the clinical spectrum of diabetes in China Diabetes Care 2011 34 7 1639 1641 21617097
   PubMed Web of Science ®Google Scholar